Diabetes Mellitus Adherence to Clinical Follow-Up, Based in Local Guidelines and Metabolical Outcomes

Abstract

A921measured by ratios of compliance. Assistance to medical services and clinical outcomes was transformed to categorically variables, Fisher's Exact test was used to determine the difference between groups. STATA V13.0 software was used to analyze data. Results: Observed clinical adherence of health care providers to the local clinical guidelines showed a global ratio of 43%. There were statistically significant differences between HbA1c, Total Cholesterol, HDL, LDL, and Clinical follow-up associated with patient's attendance to follow-ups with the Nutritionist, the Physician, the Internist, and the Ophthalmologist, in most of the cases. ConClusions: There is an important association between metabolic control and attendance to clinical services, which aid to conclude about its increased importance. However, the observed 43% of adherence to the Colombian Diabetes Guidelines, must be regarded with the utmost care for the very particular structure of the Colombian health insurance system. Specifically, such percentage can be affected by external processes experienced by the patient or simply due to the physicians' praxis. Hence, the upturn in the attendance frequency to specialists may cause an improvement in metabolic results, in consequence, lowering the hospitalization rates.

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review

“…The High Cost Account (CAC), which was created by the government in 2007 and is administered by insurers, collects healthcare data on high‐cost diseases (eg cancer, diabetes, hemophilia, rheumatic diseases, etc) 21,22,132,212,234,243,248,250,251,277 . This database has a quality control process (audit through a validation mesh and verification against the medical record) and contains demographic data, diagnosis by ICD‐10 and prescriptions.…”